Global Hyperimmune Globulin Injection Supply, Demand and Key Producers, 2023-2029

Description

The global Hyperimmune Globulin Injection market size is expected to reach $ 2866.8 million by 2029, rising at a market growth of 5.9% CAGR during the forecast period (2023-2029).

The human plasma-based hyperimmune preparation market is driven by the increasing demand for effective treatments against specific infectious diseases and other medical conditions. Hyperimmune preparations are derived from the plasma of individuals who have recovered from a particular infection or have been vaccinated against a specific pathogen. These preparations contain high levels of antibodies targeting the specific pathogen or antigen, making them valuable for passive immunization in individuals at risk or currently affected by the same disease. The growing prevalence of infectious diseases, such as COVID-19, and the need for rapid and targeted therapeutic solutions have fueled market growth. Moreover, advancements in plasma fractionation and purification technologies have improved the production and safety of hyperimmune preparations. However, the market also faces challenges, including the complexity of large-scale plasma collection and processing, ensuring consistent antibody levels in the preparations, and maintaining a robust supply chain to meet demand during disease outbreaks or pandemics. Additionally, regulatory considerations and the need for stringent safety and quality standards are crucial challenges for manufacturers. To succeed in this market, companies must focus on research and development to expand the applications of hyperimmune preparations, collaborate with healthcare authorities and organizations to establish guidelines and protocols, and work towards enhancing plasma collection infrastructure to ensure a steady supply of human plasma-based hyperimmune preparations for critical therapeutic interventions.

Hyperimmune globulin is similar to intravenous immunoglobulin (IVIG) except that it is prepared from the plasma of donors with high titers of antibody against a specific organism or antigen. Some agents against which hyperimmune globulins are available include hepatitis B, rabies, tetanus toxin, varicella-zoster, etc. Administration of hyperimmune globulin provides "passive" immunity to the patient against an agent. This is in contrast to vaccines that provide "active" immunity. However, vaccines take much longer to achieve that purpose while hyperimmune globulin provides instant "passive" short-lived immunity. Hyperimmune globulin may have serious side effects, thus usage is taken very seriously.

This report studies the global Hyperimmune Globulin Injection production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Hyperimmune Globulin Injection, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Hyperimmune Globulin Injection that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Hyperimmune Globulin Injection total production and demand, 2018-2029, (K Units)
Global Hyperimmune Globulin Injection total production value, 2018-2029, (USD Million)
Global Hyperimmune Globulin Injection production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Hyperimmune Globulin Injection consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Hyperimmune Globulin Injection domestic production, consumption, key domestic manufacturers and share
Global Hyperimmune Globulin Injection production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Hyperimmune Globulin Injection production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Hyperimmune Globulin Injection production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units).

This reports profiles key players in the global Hyperimmune Globulin Injection market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include CSL Behring, Grifols, Biotest, Kedrion, CBPO, Emergent (Cangene), Kamada, CNBG and Hualan Bio, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Hyperimmune Globulin Injection market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Hyperimmune Globulin Injection Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Hyperimmune Globulin Injection Market, Segmentation by Type
    Hepatitis B Immunoglobulins
    Rabies Immunoglobulins
    Tetanus Immunoglobulins
    Rho(D) Immunoglobulins
    Other

Global Hyperimmune Globulin Injection Market, Segmentation by Application
    Government Institution
    Private Sector
    Others

Companies Profiled:
    CSL Behring
    Grifols
    Biotest
    Kedrion
    CBPO
    Emergent (Cangene)
    Kamada
    CNBG
    Hualan Bio
    Shanghai RAAS
    Sichuan Yuanda Shuyang
    ADMA Biologics

Key Questions Answered
1. How big is the global Hyperimmune Globulin Injection market?
2. What is the demand of the global Hyperimmune Globulin Injection market?
3. What is the year over year growth of the global Hyperimmune Globulin Injection market?
4. What is the production and production value of the global Hyperimmune Globulin Injection market?
5. Who are the key producers in the global Hyperimmune Globulin Injection market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Hyperimmune Globulin Injection Introduction
    1.2 World Hyperimmune Globulin Injection Supply & Forecast
        1.2.1 World Hyperimmune Globulin Injection Production Value (2018 & 2022 & 2029)
        1.2.2 World Hyperimmune Globulin Injection Production (2018-2029)
        1.2.3 World Hyperimmune Globulin Injection Pricing Trends (2018-2029)
    1.3 World Hyperimmune Globulin Injection Production by Region (Based on Production Site)
        1.3.1 World Hyperimmune Globulin Injection Production Value by Region (2018-2029)
        1.3.2 World Hyperimmune Globulin Injection Production by Region (2018-2029)
        1.3.3 World Hyperimmune Globulin Injection Average Price by Region (2018-2029)
        1.3.4 North America Hyperimmune Globulin Injection Production (2018-2029)
        1.3.5 Europe Hyperimmune Globulin Injection Production (2018-2029)
        1.3.6 China Hyperimmune Globulin Injection Production (2018-2029)
        1.3.7 Japan Hyperimmune Globulin Injection Production (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Hyperimmune Globulin Injection Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Hyperimmune Globulin Injection Major Market Trends
    1.5 Influence of COVID-19 and Russia-Ukraine War
        1.5.1 Influence of COVID-19
        1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
    2.1 World Hyperimmune Globulin Injection Demand (2018-2029)
    2.2 World Hyperimmune Globulin Injection Consumption by Region
        2.2.1 World Hyperimmune Globulin Injection Consumption by Region (2018-2023)
        2.2.2 World Hyperimmune Globulin Injection Consumption Forecast by Region (2024-2029)
    2.3 United States Hyperimmune Globulin Injection Consumption (2018-2029)
    2.4 China Hyperimmune Globulin Injection Consumption (2018-2029)
    2.5 Europe Hyperimmune Globulin Injection Consumption (2018-2029)
    2.6 Japan Hyperimmune Globulin Injection Consumption (2018-2029)
    2.7 South Korea Hyperimmune Globulin Injection Consumption (2018-2029)
    2.8 ASEAN Hyperimmune Globulin Injection Consumption (2018-2029)
    2.9 India Hyperimmune Globulin Injection Consumption (2018-2029)

3 World Hyperimmune Globulin Injection Manufacturers Competitive Analysis
    3.1 World Hyperimmune Globulin Injection Production Value by Manufacturer (2018-2023)
    3.2 World Hyperimmune Globulin Injection Production by Manufacturer (2018-2023)
    3.3 World Hyperimmune Globulin Injection Average Price by Manufacturer (2018-2023)
    3.4 Hyperimmune Globulin Injection Company Evaluation Quadrant
    3.5 Industry Rank and Concentration Rate (CR)
        3.5.1 Global Hyperimmune Globulin Injection Industry Rank of Major Manufacturers
        3.5.2 Global Concentration Ratios (CR4) for Hyperimmune Globulin Injection in 2022
        3.5.3 Global Concentration Ratios (CR8) for Hyperimmune Globulin Injection in 2022
    3.6 Hyperimmune Globulin Injection Market: Overall Company Footprint Analysis
        3.6.1 Hyperimmune Globulin Injection Market: Region Footprint
        3.6.2 Hyperimmune Globulin Injection Market: Company Product Type Footprint
        3.6.3 Hyperimmune Globulin Injection Market: Company Product Application Footprint
    3.7 Competitive Environment
        3.7.1 Historical Structure of the Industry
        3.7.2 Barriers of Market Entry
        3.7.3 Factors of Competition
    3.8 New Entrant and Capacity Expansion Plans
    3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
    4.1 United States VS China: Hyperimmune Globulin Injection Production Value Comparison
        4.1.1 United States VS China: Hyperimmune Globulin Injection Production Value Comparison (2018 & 2022 & 2029)
        4.1.2 United States VS China: Hyperimmune Globulin Injection Production Value Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States VS China: Hyperimmune Globulin Injection Production Comparison
        4.2.1 United States VS China: Hyperimmune Globulin Injection Production Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: Hyperimmune Globulin Injection Production Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States VS China: Hyperimmune Globulin Injection Consumption Comparison
        4.3.1 United States VS China: Hyperimmune Globulin Injection Consumption Comparison (2018 & 2022 & 2029)
        4.3.2 United States VS China: Hyperimmune Globulin Injection Consumption Market Share Comparison (2018 & 2022 & 2029)
    4.4 United States Based Hyperimmune Globulin Injection Manufacturers and Market Share, 2018-2023
        4.4.1 United States Based Hyperimmune Globulin Injection Manufacturers, Headquarters and Production Site (States, Country)
        4.4.2 United States Based Manufacturers Hyperimmune Globulin Injection Production Value (2018-2023)
        4.4.3 United States Based Manufacturers Hyperimmune Globulin Injection Production (2018-2023)
    4.5 China Based Hyperimmune Globulin Injection Manufacturers and Market Share
        4.5.1 China Based Hyperimmune Globulin Injection Manufacturers, Headquarters and Production Site (Province, Country)
        4.5.2 China Based Manufacturers Hyperimmune Globulin Injection Production Value (2018-2023)
        4.5.3 China Based Manufacturers Hyperimmune Globulin Injection Production (2018-2023)
    4.6 Rest of World Based Hyperimmune Globulin Injection Manufacturers and Market Share, 2018-2023
        4.6.1 Rest of World Based Hyperimmune Globulin Injection Manufacturers, Headquarters and Production Site (State, Country)
        4.6.2 Rest of World Based Manufacturers Hyperimmune Globulin Injection Production Value (2018-2023)
        4.6.3 Rest of World Based Manufacturers Hyperimmune Globulin Injection Production (2018-2023)

5 Market Analysis by Type
    5.1 World Hyperimmune Globulin Injection Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 Hepatitis B Immunoglobulins
        5.2.2 Rabies Immunoglobulins
        5.2.3 Tetanus Immunoglobulins
        5.2.4 Rho(D) Immunoglobulins
        5.2.5 Other
    5.3 Market Segment by Type
        5.3.1 World Hyperimmune Globulin Injection Production by Type (2018-2029)
        5.3.2 World Hyperimmune Globulin Injection Production Value by Type (2018-2029)
        5.3.3 World Hyperimmune Globulin Injection Average Price by Type (2018-2029)

6 Market Analysis by Application
    6.1 World Hyperimmune Globulin Injection Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Government Institution
        6.2.2 Private Sector
        6.2.3 Others
    6.3 Market Segment by Application
        6.3.1 World Hyperimmune Globulin Injection Production by Application (2018-2029)
        6.3.2 World Hyperimmune Globulin Injection Production Value by Application (2018-2029)
        6.3.3 World Hyperimmune Globulin Injection Average Price by Application (2018-2029)

7 Company Profiles
    7.1 CSL Behring
        7.1.1 CSL Behring Details
        7.1.2 CSL Behring Major Business
        7.1.3 CSL Behring Hyperimmune Globulin Injection Product and Services
        7.1.4 CSL Behring Hyperimmune Globulin Injection Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.1.5 CSL Behring Recent Developments/Updates
        7.1.6 CSL Behring Competitive Strengths & Weaknesses
    7.2 Grifols
        7.2.1 Grifols Details
        7.2.2 Grifols Major Business
        7.2.3 Grifols Hyperimmune Globulin Injection Product and Services
        7.2.4 Grifols Hyperimmune Globulin Injection Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.2.5 Grifols Recent Developments/Updates
        7.2.6 Grifols Competitive Strengths & Weaknesses
    7.3 Biotest
        7.3.1 Biotest Details
        7.3.2 Biotest Major Business
        7.3.3 Biotest Hyperimmune Globulin Injection Product and Services
        7.3.4 Biotest Hyperimmune Globulin Injection Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.3.5 Biotest Recent Developments/Updates
        7.3.6 Biotest Competitive Strengths & Weaknesses
    7.4 Kedrion
        7.4.1 Kedrion Details
        7.4.2 Kedrion Major Business
        7.4.3 Kedrion Hyperimmune Globulin Injection Product and Services
        7.4.4 Kedrion Hyperimmune Globulin Injection Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.4.5 Kedrion Recent Developments/Updates
        7.4.6 Kedrion Competitive Strengths & Weaknesses
    7.5 CBPO
        7.5.1 CBPO Details
        7.5.2 CBPO Major Business
        7.5.3 CBPO Hyperimmune Globulin Injection Product and Services
        7.5.4 CBPO Hyperimmune Globulin Injection Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.5.5 CBPO Recent Developments/Updates
        7.5.6 CBPO Competitive Strengths & Weaknesses
    7.6 Emergent (Cangene)
        7.6.1 Emergent (Cangene) Details
        7.6.2 Emergent (Cangene) Major Business
        7.6.3 Emergent (Cangene) Hyperimmune Globulin Injection Product and Services
        7.6.4 Emergent (Cangene) Hyperimmune Globulin Injection Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.6.5 Emergent (Cangene) Recent Developments/Updates
        7.6.6 Emergent (Cangene) Competitive Strengths & Weaknesses
    7.7 Kamada
        7.7.1 Kamada Details
        7.7.2 Kamada Major Business
        7.7.3 Kamada Hyperimmune Globulin Injection Product and Services
        7.7.4 Kamada Hyperimmune Globulin Injection Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.7.5 Kamada Recent Developments/Updates
        7.7.6 Kamada Competitive Strengths & Weaknesses
    7.8 CNBG
        7.8.1 CNBG Details
        7.8.2 CNBG Major Business
        7.8.3 CNBG Hyperimmune Globulin Injection Product and Services
        7.8.4 CNBG Hyperimmune Globulin Injection Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.8.5 CNBG Recent Developments/Updates
        7.8.6 CNBG Competitive Strengths & Weaknesses
    7.9 Hualan Bio
        7.9.1 Hualan Bio Details
        7.9.2 Hualan Bio Major Business
        7.9.3 Hualan Bio Hyperimmune Globulin Injection Product and Services
        7.9.4 Hualan Bio Hyperimmune Globulin Injection Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.9.5 Hualan Bio Recent Developments/Updates
        7.9.6 Hualan Bio Competitive Strengths & Weaknesses
    7.10 Shanghai RAAS
        7.10.1 Shanghai RAAS Details
        7.10.2 Shanghai RAAS Major Business
        7.10.3 Shanghai RAAS Hyperimmune Globulin Injection Product and Services
        7.10.4 Shanghai RAAS Hyperimmune Globulin Injection Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.10.5 Shanghai RAAS Recent Developments/Updates
        7.10.6 Shanghai RAAS Competitive Strengths & Weaknesses
    7.11 Sichuan Yuanda Shuyang
        7.11.1 Sichuan Yuanda Shuyang Details
        7.11.2 Sichuan Yuanda Shuyang Major Business
        7.11.3 Sichuan Yuanda Shuyang Hyperimmune Globulin Injection Product and Services
        7.11.4 Sichuan Yuanda Shuyang Hyperimmune Globulin Injection Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.11.5 Sichuan Yuanda Shuyang Recent Developments/Updates
        7.11.6 Sichuan Yuanda Shuyang Competitive Strengths & Weaknesses
    7.12 ADMA Biologics
        7.12.1 ADMA Biologics Details
        7.12.2 ADMA Biologics Major Business
        7.12.3 ADMA Biologics Hyperimmune Globulin Injection Product and Services
        7.12.4 ADMA Biologics Hyperimmune Globulin Injection Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.12.5 ADMA Biologics Recent Developments/Updates
        7.12.6 ADMA Biologics Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Hyperimmune Globulin Injection Industry Chain
    8.2 Hyperimmune Globulin Injection Upstream Analysis
        8.2.1 Hyperimmune Globulin Injection Core Raw Materials
        8.2.2 Main Manufacturers of Hyperimmune Globulin Injection Core Raw Materials
    8.3 Midstream Analysis
    8.4 Downstream Analysis
    8.5 Hyperimmune Globulin Injection Production Mode
    8.6 Hyperimmune Globulin Injection Procurement Model
    8.7 Hyperimmune Globulin Injection Industry Sales Model and Sales Channels
        8.7.1 Hyperimmune Globulin Injection Sales Model
        8.7.2 Hyperimmune Globulin Injection Typical Customers

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Hyperimmune Globulin Injection Production Value by Region (2018, 2022 and 2029) & (USD Million)
    Table 2. World Hyperimmune Globulin Injection Production Value by Region (2018-2023) & (USD Million)
    Table 3. World Hyperimmune Globulin Injection Production Value by Region (2024-2029) & (USD Million)
    Table 4. World Hyperimmune Globulin Injection Production Value Market Share by Region (2018-2023)
    Table 5. World Hyperimmune Globulin Injection Production Value Market Share by Region (2024-2029)
    Table 6. World Hyperimmune Globulin Injection Production by Region (2018-2023) & (K Units)
    Table 7. World Hyperimmune Globulin Injection Production by Region (2024-2029) & (K Units)
    Table 8. World Hyperimmune Globulin Injection Production Market Share by Region (2018-2023)
    Table 9. World Hyperimmune Globulin Injection Production Market Share by Region (2024-2029)
    Table 10. World Hyperimmune Globulin Injection Average Price by Region (2018-2023) & (US$/Unit)
    Table 11. World Hyperimmune Globulin Injection Average Price by Region (2024-2029) & (US$/Unit)
    Table 12. Hyperimmune Globulin Injection Major Market Trends
    Table 13. World Hyperimmune Globulin Injection Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
    Table 14. World Hyperimmune Globulin Injection Consumption by Region (2018-2023) & (K Units)
    Table 15. World Hyperimmune Globulin Injection Consumption Forecast by Region (2024-2029) & (K Units)
    Table 16. World Hyperimmune Globulin Injection Production Value by Manufacturer (2018-2023) & (USD Million)
    Table 17. Production Value Market Share of Key Hyperimmune Globulin Injection Producers in 2022
    Table 18. World Hyperimmune Globulin Injection Production by Manufacturer (2018-2023) & (K Units)
    Table 19. Production Market Share of Key Hyperimmune Globulin Injection Producers in 2022
    Table 20. World Hyperimmune Globulin Injection Average Price by Manufacturer (2018-2023) & (US$/Unit)
    Table 21. Global Hyperimmune Globulin Injection Company Evaluation Quadrant
    Table 22. World Hyperimmune Globulin Injection Industry Rank of Major Manufacturers, Based on Production Value in 2022
    Table 23. Head Office and Hyperimmune Globulin Injection Production Site of Key Manufacturer
    Table 24. Hyperimmune Globulin Injection Market: Company Product Type Footprint
    Table 25. Hyperimmune Globulin Injection Market: Company Product Application Footprint
    Table 26. Hyperimmune Globulin Injection Competitive Factors
    Table 27. Hyperimmune Globulin Injection New Entrant and Capacity Expansion Plans
    Table 28. Hyperimmune Globulin Injection Mergers & Acquisitions Activity
    Table 29. United States VS China Hyperimmune Globulin Injection Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 30. United States VS China Hyperimmune Globulin Injection Production Comparison, (2018 & 2022 & 2029) & (K Units)
    Table 31. United States VS China Hyperimmune Globulin Injection Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
    Table 32. United States Based Hyperimmune Globulin Injection Manufacturers, Headquarters and Production Site (States, Country)
    Table 33. United States Based Manufacturers Hyperimmune Globulin Injection Production Value, (2018-2023) & (USD Million)
    Table 34. United States Based Manufacturers Hyperimmune Globulin Injection Production Value Market Share (2018-2023)
    Table 35. United States Based Manufacturers Hyperimmune Globulin Injection Production (2018-2023) & (K Units)
    Table 36. United States Based Manufacturers Hyperimmune Globulin Injection Production Market Share (2018-2023)
    Table 37. China Based Hyperimmune Globulin Injection Manufacturers, Headquarters and Production Site (Province, Country)
    Table 38. China Based Manufacturers Hyperimmune Globulin Injection Production Value, (2018-2023) & (USD Million)
    Table 39. China Based Manufacturers Hyperimmune Globulin Injection Production Value Market Share (2018-2023)
    Table 40. China Based Manufacturers Hyperimmune Globulin Injection Production (2018-2023) & (K Units)
    Table 41. China Based Manufacturers Hyperimmune Globulin Injection Production Market Share (2018-2023)
    Table 42. Rest of World Based Hyperimmune Globulin Injection Manufacturers, Headquarters and Production Site (States, Country)
    Table 43. Rest of World Based Manufacturers Hyperimmune Globulin Injection Production Value, (2018-2023) & (USD Million)
    Table 44. Rest of World Based Manufacturers Hyperimmune Globulin Injection Production Value Market Share (2018-2023)
    Table 45. Rest of World Based Manufacturers Hyperimmune Globulin Injection Production (2018-2023) & (K Units)
    Table 46. Rest of World Based Manufacturers Hyperimmune Globulin Injection Production Market Share (2018-2023)
    Table 47. World Hyperimmune Globulin Injection Production Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 48. World Hyperimmune Globulin Injection Production by Type (2018-2023) & (K Units)
    Table 49. World Hyperimmune Globulin Injection Production by Type (2024-2029) & (K Units)
    Table 50. World Hyperimmune Globulin Injection Production Value by Type (2018-2023) & (USD Million)
    Table 51. World Hyperimmune Globulin Injection Production Value by Type (2024-2029) & (USD Million)
    Table 52. World Hyperimmune Globulin Injection Average Price by Type (2018-2023) & (US$/Unit)
    Table 53. World Hyperimmune Globulin Injection Average Price by Type (2024-2029) & (US$/Unit)
    Table 54. World Hyperimmune Globulin Injection Production Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 55. World Hyperimmune Globulin Injection Production by Application (2018-2023) & (K Units)
    Table 56. World Hyperimmune Globulin Injection Production by Application (2024-2029) & (K Units)
    Table 57. World Hyperimmune Globulin Injection Production Value by Application (2018-2023) & (USD Million)
    Table 58. World Hyperimmune Globulin Injection Production Value by Application (2024-2029) & (USD Million)
    Table 59. World Hyperimmune Globulin Injection Average Price by Application (2018-2023) & (US$/Unit)
    Table 60. World Hyperimmune Globulin Injection Average Price by Application (2024-2029) & (US$/Unit)
    Table 61. CSL Behring Basic Information, Manufacturing Base and Competitors
    Table 62. CSL Behring Major Business
    Table 63. CSL Behring Hyperimmune Globulin Injection Product and Services
    Table 64. CSL Behring Hyperimmune Globulin Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 65. CSL Behring Recent Developments/Updates
    Table 66. CSL Behring Competitive Strengths & Weaknesses
    Table 67. Grifols Basic Information, Manufacturing Base and Competitors
    Table 68. Grifols Major Business
    Table 69. Grifols Hyperimmune Globulin Injection Product and Services
    Table 70. Grifols Hyperimmune Globulin Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 71. Grifols Recent Developments/Updates
    Table 72. Grifols Competitive Strengths & Weaknesses
    Table 73. Biotest Basic Information, Manufacturing Base and Competitors
    Table 74. Biotest Major Business
    Table 75. Biotest Hyperimmune Globulin Injection Product and Services
    Table 76. Biotest Hyperimmune Globulin Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 77. Biotest Recent Developments/Updates
    Table 78. Biotest Competitive Strengths & Weaknesses
    Table 79. Kedrion Basic Information, Manufacturing Base and Competitors
    Table 80. Kedrion Major Business
    Table 81. Kedrion Hyperimmune Globulin Injection Product and Services
    Table 82. Kedrion Hyperimmune Globulin Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 83. Kedrion Recent Developments/Updates
    Table 84. Kedrion Competitive Strengths & Weaknesses
    Table 85. CBPO Basic Information, Manufacturing Base and Competitors
    Table 86. CBPO Major Business
    Table 87. CBPO Hyperimmune Globulin Injection Product and Services
    Table 88. CBPO Hyperimmune Globulin Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 89. CBPO Recent Developments/Updates
    Table 90. CBPO Competitive Strengths & Weaknesses
    Table 91. Emergent (Cangene) Basic Information, Manufacturing Base and Competitors
    Table 92. Emergent (Cangene) Major Business
    Table 93. Emergent (Cangene) Hyperimmune Globulin Injection Product and Services
    Table 94. Emergent (Cangene) Hyperimmune Globulin Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 95. Emergent (Cangene) Recent Developments/Updates
    Table 96. Emergent (Cangene) Competitive Strengths & Weaknesses
    Table 97. Kamada Basic Information, Manufacturing Base and Competitors
    Table 98. Kamada Major Business
    Table 99. Kamada Hyperimmune Globulin Injection Product and Services
    Table 100. Kamada Hyperimmune Globulin Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 101. Kamada Recent Developments/Updates
    Table 102. Kamada Competitive Strengths & Weaknesses
    Table 103. CNBG Basic Information, Manufacturing Base and Competitors
    Table 104. CNBG Major Business
    Table 105. CNBG Hyperimmune Globulin Injection Product and Services
    Table 106. CNBG Hyperimmune Globulin Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 107. CNBG Recent Developments/Updates
    Table 108. CNBG Competitive Strengths & Weaknesses
    Table 109. Hualan Bio Basic Information, Manufacturing Base and Competitors
    Table 110. Hualan Bio Major Business
    Table 111. Hualan Bio Hyperimmune Globulin Injection Product and Services
    Table 112. Hualan Bio Hyperimmune Globulin Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 113. Hualan Bio Recent Developments/Updates
    Table 114. Hualan Bio Competitive Strengths & Weaknesses
    Table 115. Shanghai RAAS Basic Information, Manufacturing Base and Competitors
    Table 116. Shanghai RAAS Major Business
    Table 117. Shanghai RAAS Hyperimmune Globulin Injection Product and Services
    Table 118. Shanghai RAAS Hyperimmune Globulin Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 119. Shanghai RAAS Recent Developments/Updates
    Table 120. Shanghai RAAS Competitive Strengths & Weaknesses
    Table 121. Sichuan Yuanda Shuyang Basic Information, Manufacturing Base and Competitors
    Table 122. Sichuan Yuanda Shuyang Major Business
    Table 123. Sichuan Yuanda Shuyang Hyperimmune Globulin Injection Product and Services
    Table 124. Sichuan Yuanda Shuyang Hyperimmune Globulin Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 125. Sichuan Yuanda Shuyang Recent Developments/Updates
    Table 126. ADMA Biologics Basic Information, Manufacturing Base and Competitors
    Table 127. ADMA Biologics Major Business
    Table 128. ADMA Biologics Hyperimmune Globulin Injection Product and Services
    Table 129. ADMA Biologics Hyperimmune Globulin Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 130. Global Key Players of Hyperimmune Globulin Injection Upstream (Raw Materials)
    Table 131. Hyperimmune Globulin Injection Typical Customers
    Table 132. Hyperimmune Globulin Injection Typical Distributors
List of Figure
    Figure 1. Hyperimmune Globulin Injection Picture
    Figure 2. World Hyperimmune Globulin Injection Production Value: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World Hyperimmune Globulin Injection Production Value and Forecast (2018-2029) & (USD Million)
    Figure 4. World Hyperimmune Globulin Injection Production (2018-2029) & (K Units)
    Figure 5. World Hyperimmune Globulin Injection Average Price (2018-2029) & (US$/Unit)
    Figure 6. World Hyperimmune Globulin Injection Production Value Market Share by Region (2018-2029)
    Figure 7. World Hyperimmune Globulin Injection Production Market Share by Region (2018-2029)
    Figure 8. North America Hyperimmune Globulin Injection Production (2018-2029) & (K Units)
    Figure 9. Europe Hyperimmune Globulin Injection Production (2018-2029) & (K Units)
    Figure 10. China Hyperimmune Globulin Injection Production (2018-2029) & (K Units)
    Figure 11. Japan Hyperimmune Globulin Injection Production (2018-2029) & (K Units)
    Figure 12. Hyperimmune Globulin Injection Market Drivers
    Figure 13. Factors Affecting Demand
    Figure 14. World Hyperimmune Globulin Injection Consumption (2018-2029) & (K Units)
    Figure 15. World Hyperimmune Globulin Injection Consumption Market Share by Region (2018-2029)
    Figure 16. United States Hyperimmune Globulin Injection Consumption (2018-2029) & (K Units)
    Figure 17. China Hyperimmune Globulin Injection Consumption (2018-2029) & (K Units)
    Figure 18. Europe Hyperimmune Globulin Injection Consumption (2018-2029) & (K Units)
    Figure 19. Japan Hyperimmune Globulin Injection Consumption (2018-2029) & (K Units)
    Figure 20. South Korea Hyperimmune Globulin Injection Consumption (2018-2029) & (K Units)
    Figure 21. ASEAN Hyperimmune Globulin Injection Consumption (2018-2029) & (K Units)
    Figure 22. India Hyperimmune Globulin Injection Consumption (2018-2029) & (K Units)
    Figure 23. Producer Shipments of Hyperimmune Globulin Injection by Manufacturer Revenue ($MM) and Market Share (%): 2022
    Figure 24. Global Four-firm Concentration Ratios (CR4) for Hyperimmune Globulin Injection Markets in 2022
    Figure 25. Global Four-firm Concentration Ratios (CR8) for Hyperimmune Globulin Injection Markets in 2022
    Figure 26. United States VS China: Hyperimmune Globulin Injection Production Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 27. United States VS China: Hyperimmune Globulin Injection Production Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: Hyperimmune Globulin Injection Consumption Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. United States Based Manufacturers Hyperimmune Globulin Injection Production Market Share 2022
    Figure 30. China Based Manufacturers Hyperimmune Globulin Injection Production Market Share 2022
    Figure 31. Rest of World Based Manufacturers Hyperimmune Globulin Injection Production Market Share 2022
    Figure 32. World Hyperimmune Globulin Injection Production Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 33. World Hyperimmune Globulin Injection Production Value Market Share by Type in 2022
    Figure 34. Hepatitis B Immunoglobulins
    Figure 35. Rabies Immunoglobulins
    Figure 36. Tetanus Immunoglobulins
    Figure 37. Rho(D) Immunoglobulins
    Figure 38. Other
    Figure 39. World Hyperimmune Globulin Injection Production Market Share by Type (2018-2029)
    Figure 40. World Hyperimmune Globulin Injection Production Value Market Share by Type (2018-2029)
    Figure 41. World Hyperimmune Globulin Injection Average Price by Type (2018-2029) & (US$/Unit)
    Figure 42. World Hyperimmune Globulin Injection Production Value by Application, (USD Million), 2018 & 2022 & 2029
    Figure 43. World Hyperimmune Globulin Injection Production Value Market Share by Application in 2022
    Figure 44. Government Institution
    Figure 45. Private Sector
    Figure 46. Others
    Figure 47. World Hyperimmune Globulin Injection Production Market Share by Application (2018-2029)
    Figure 48. World Hyperimmune Globulin Injection Production Value Market Share by Application (2018-2029)
    Figure 49. World Hyperimmune Globulin Injection Average Price by Application (2018-2029) & (US$/Unit)
    Figure 50. Hyperimmune Globulin Injection Industry Chain
    Figure 51. Hyperimmune Globulin Injection Procurement Model
    Figure 52. Hyperimmune Globulin Injection Sales Model
    Figure 53. Hyperimmune Globulin Injection Sales Channels, Direct Sales, and Distribution
    Figure 54. Methodology
    Figure 55. Research Process and Data Source

Companies Mentioned

CSL Behring
Grifols
Biotest
Kedrion
CBPO
Emergent (Cangene)
Kamada
CNBG
Hualan Bio
Shanghai RAAS
Sichuan Yuanda Shuyang
ADMA Biologics